Reconsideration of the laminin receptor 67LR in colorectal cancer cells.


Journal

Biomolecules & biomedicine
ISSN: 2831-090X
Titre abrégé: Biomol Biomed
Pays: Bosnia and Herzegovina
ID NLM: 9918522188506676

Informations de publication

Date de publication:
11 Apr 2024
Historique:
received: 30 01 2024
accepted: 04 04 2024
medline: 12 4 2024
pubmed: 12 4 2024
entrez: 12 4 2024
Statut: aheadofprint

Résumé

The 67 kDa laminin receptor (67LR) was identified as the first laminin receptor shown to be involved in the carcinogenesis of various cancers, including colorectal cancer. While the exact composition of this 67 kDa receptor remains unknown, it has been reported to be formed by the 37 kDa ribosomal protein SA (RPSA) covalently attached to another unidentified protein. Our analysis of 67LR in colorectal cancer cell extracts showed the 67 kDa immunoreactive protein corresponding to 67LR in the soluble protein fraction, while some 37 kDa RPSA exhibited plasma membrane-like properties. Proteomic analysis of the 67 kDa fraction revealed the absence of RPSA, however, the β-galactosidase-related 67 kDa elastin-binding protein, another laminin binding receptor, was identified. The downregulation of β-galactosidase through short hairpin RNA (shRNA) led to a reduction in both 67LR and 67EBP immunoreactive proteins, indicating a possible misidentification of 67LR and 67EBP in colorectal cancer cells.

Identifiants

pubmed: 38606907
doi: 10.17305/bb.2024.10323
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Gabriel Cloutier (G)

Laboratory of Intestinal Physiopathology, Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada.

Jean-François Beaulieu (JF)

Laboratory of Intestinal Physiopathology, Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada.

Classifications MeSH